Aim Osteoimmunology covers the cellular and molecular mechanisms responsible for
inflammatory osteolysis that culminates in the degradation of alveolar bone …

Medication related osteonecrosis of the jaws (MRONJ) and osteoradionecrosis of the jaws
(ORNJ) are two different diseases of quite similar appearance. MRONJ is mainly due to …

Medication-related osteonecrosis of the jaw (MRONJ) is defined by the American
Association of Oral and Maxillofacial Surgeons (AAOMS) as the presence of an exposed …

This study evaluated the effects of antimicrobial photodynamic therapy (aPDT) in the
alveolar repair of rats with major risk factors for bisphosphonate-related osteonecrosis of the …

Members of the Actinomyces genus and Actinomyces-like organisms (ALOs; namely
Actinotignum, Arcanobacterium, Schaalia and Varibaculum) are Gram-positive, non-spore …

Objective This manuscript aims to provide a comprehensive review of the current knowledge
in the pathophysiology, diagnosis, prevention, and other relevant forensic and clinical …

Bone-modifying agents (BMAs) are integral to managing patients with advanced cancer.
They improve quality of survival by reducing skeletal-related events, treating …

Background: Nearly two decades have passed since a paradoxical reaction in the orofacial
region to some bone modifying agents and other drugs was recognized, namely medication …

The pathogenesis of medication-related osteonecrosis of the jaw (MRONJ) is multifactorial
and there is a substantial consensus on the role of antiresorptive drugs (ARDs), including …

Objectives The aim of this study was to investigate the relationship between M1 and M2
macrophage polarization and clinical stage in patients with medication-related …